WHO SMART Guidelines - Example Workshop IG
0.1.0 - ci-build
WHO SMART Guidelines - Example Workshop IG, published by WHO. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/brynrhodes/smart-workshop/ and changes regularly. See the Directory of published versions
| Draft as of 2024-12-02 |
<PlanDefinition xmlns="http://hl7.org/fhir">
<id value="IMMZD2DTMeaslesOT"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-recommendationdefinition"/>
<profile
value="http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-shareableplandefinition"/>
<profile
value="http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-publishableplandefinition"/>
</meta>
<text>
<status value="extensions"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: PlanDefinition IMMZD2DTMeaslesOT</b></p><a name="IMMZD2DTMeaslesOT"> </a><a name="hcIMMZD2DTMeaslesOT"> </a><a name="IMMZD2DTMeaslesOT-en-US"> </a><p><b>CQF Knowledge capability</b>: computable</p><p><b>url</b>: <a href="PlanDefinition-IMMZD2DTMeaslesOT.html">PlanDefinition IMMZ.D2.DT.Measles Ongoing Transmission</a></p><p><b>version</b>: 0.1.0</p><p><b>name</b>: IMMZD2DTMeaslesOT</p><p><b>title</b>: IMMZ.D2.DT.Measles Ongoing Transmission</p><p><b>type</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/plan-definition-type eca-rule}">ECA Rule</span></p><p><b>status</b>: Draft</p><p><b>experimental</b>: true</p><p><b>date</b>: 2024-12-02 20:31:54+0000</p><p><b>publisher</b>: WHO</p><p><b>contact</b>: WHO: <a href="http://who.int">http://who.int</a></p><p><b>description</b>: </p><div><p>If the child or patient has not been given MCV1 (at 9 months) and MCV2 (between 15-18 months) vaccination</p>
</div><h3>RelatedArtifacts</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>Citation</b></td></tr><tr><td style="display: none">*</td><td>Citation</td><td><div><p>WHO recommendations for routine immunization - summary tables (March 2023)</p>
</div></td></tr></table><p><b>library</b>: <a href="Library-IMMZD2DTMeaslesOTLogic.html">IMMZD2DTMeaslesOTLogic</a></p><blockquote><p><b>action</b></p><p><b>title</b>: Immunize patient for Measles</p><blockquote><p><b>condition</b></p><p><b>kind</b>: Applicability</p><h3>Expressions</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Language</b></td><td><b>Expression</b></td></tr><tr><td style="display: none">*</td><td>text/cql-identifier</td><td>Measles Routine Immunization Schedule Incomplete</td></tr></table></blockquote><blockquote><p><b>action</b></p><p><b>CPG Rationale Extension</b>: </p><div><p>In countries with ongoing transmission in which the risk of measles mortality remains high, MCV1 should be given at age 9 months.<br/>As a general rule, live vaccines should be given either simultaneously or at intervals of 4 weeks. An exception to this rule is OPV, which can be given at any time before or after measles vaccination without interference in the response to either vaccine.</p>
</div><p><b>title</b>: Provide primary series measles vaccination (MCV1)</p><blockquote><p><b>condition</b></p><p><b>kind</b>: Applicability</p><h3>Expressions</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Language</b></td><td><b>Expression</b></td></tr><tr><td style="display: none">*</td><td>text/cql-identifier</td><td>No Primary Series Doses Administered</td></tr></table></blockquote><blockquote><p><b>action</b></p><p><b>title</b>: Client Age Less Than 9 Months</p><p><b>description</b>: Should not vaccinate client as client's age is less than 9 months. Check for any vaccines due, and inform the caregiver of when to come back for MCV1.</p><blockquote><p><b>condition</b></p><p><b>kind</b>: Applicability</p><h3>Expressions</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Language</b></td><td><b>Expression</b></td></tr><tr><td style="display: none">*</td><td>text/cql-identifier</td><td>Client Age Less Than 9 Months</td></tr></table></blockquote></blockquote><blockquote><p><b>action</b></p><p><b>title</b>: Last Live Vaccine Administered Within 4 Weeks</p><p><b>description</b>: Should not vaccinate client for MCV1 as live vaccine was administered in the last 4 weeks. Check for any vaccines due and inform the caregiver of when to come back for MCV1.</p><blockquote><p><b>condition</b></p><p><b>kind</b>: Applicability</p><h3>Expressions</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Language</b></td><td><b>Expression</b></td></tr><tr><td style="display: none">*</td><td>text/cql-identifier</td><td>Last Live Vaccine Administered Within 4 Weeks</td></tr></table></blockquote></blockquote><blockquote><p><b>action</b></p><p><b>title</b>: Provide Measles Vaccine</p><p><b>description</b>: Should vaccinate client for MCV1 as no measles doses were administered, client is within appropriate age range and no live vaccine administered in the last 4 weeks. Check for contraindications.</p><blockquote><p><b>condition</b></p><p><b>kind</b>: Applicability</p><h3>Expressions</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Language</b></td><td><b>Expression</b></td></tr><tr><td style="display: none">*</td><td>text/cql-identifier</td><td>Client Is Due For MCV1</td></tr></table></blockquote><p><b>definition</b>: <a href="ActivityDefinition-IMMZD2DTMeaslesMR.html">IMMZ.D2.DT.Measles.MR</a></p><blockquote><p><b>dynamicValue</b></p><p><b>path</b>: dispenseRequest.validityPeriod.start</p><h3>Expressions</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Description</b></td><td><b>Language</b></td><td><b>Expression</b></td></tr><tr><td style="display: none">*</td><td>Due date of the dose</td><td>text/cql-identifier</td><td>MCV1 Schedule Date</td></tr></table></blockquote><blockquote><p><b>dynamicValue</b></p><p><b>path</b>: dispenseRequest.validityPeriod.end</p><h3>Expressions</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Description</b></td><td><b>Language</b></td><td><b>Expression</b></td></tr><tr><td style="display: none">*</td><td>Expiration date for MCV dose</td><td>text/cql-identifier</td><td>MCV1 Expiration Date</td></tr></table></blockquote></blockquote></blockquote><blockquote><p><b>action</b></p><p><b>CPG Rationale Extension</b>: </p><div><p>In countries with ongoing transmission in which the risk of measles mortality remains high, MCV2 should be given between 15-18 months. The minimum interval between MCV1 and MCV2 is 4 weeks.<br/>As a general rule, live vaccines should be given either simultaneously or at intervals of 4 weeks. An exception to this rule is OPV, which can be given at any time before or after measles vaccination without interference in the response to either vaccine.</p>
</div><p><b>title</b>: Provide primary series measles vaccination (MCV2)</p><blockquote><p><b>condition</b></p><p><b>kind</b>: Applicability</p><h3>Expressions</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Language</b></td><td><b>Expression</b></td></tr><tr><td style="display: none">*</td><td>text/cql-identifier</td><td>One Primary Series Dose Administered</td></tr></table></blockquote><blockquote><p><b>action</b></p><p><b>title</b>: Client Age Less Than 15 Months</p><p><b>description</b>: Should not vaccinate client for MCV2 as client's age is less than 15 months. Check for any vaccines due, and inform the caregiver of when to come back for MCV2.</p><blockquote><p><b>condition</b></p><p><b>kind</b>: Applicability</p><h3>Expressions</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Language</b></td><td><b>Expression</b></td></tr><tr><td style="display: none">*</td><td>text/cql-identifier</td><td>Client Age Less Than 15 Months</td></tr></table></blockquote></blockquote><blockquote><p><b>action</b></p><p><b>title</b>: Last Live Vaccine Administered Within 4 Weeks</p><p><b>description</b>: Should not vaccinate client for MCV2 as live vaccine was administered in the last 4 weeks. Check for any vaccines due, and inform the caregiver of when to come back for MCV2.</p><blockquote><p><b>condition</b></p><p><b>kind</b>: Applicability</p><h3>Expressions</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Language</b></td><td><b>Expression</b></td></tr><tr><td style="display: none">*</td><td>text/cql-identifier</td><td>Last Live Vaccine Administered Within 4 Weeks</td></tr></table></blockquote></blockquote><blockquote><p><b>action</b></p><p><b>title</b>: Provide Measles Vaccine</p><p><b>description</b>: Should vaccinate client for MCV2 as client is within appropriate age range and no live vaccine administered in the last 4 weeks. Check for contraindications.</p><blockquote><p><b>condition</b></p><p><b>kind</b>: Applicability</p><h3>Expressions</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Language</b></td><td><b>Expression</b></td></tr><tr><td style="display: none">*</td><td>text/cql-identifier</td><td>Client Is Due For MCV2</td></tr></table></blockquote><p><b>definition</b>: <a href="ActivityDefinition-IMMZD2DTMeaslesMR.html">IMMZ.D2.DT.Measles.MR</a></p><blockquote><p><b>dynamicValue</b></p><p><b>path</b>: dispenseRequest.validityPeriod.start</p><h3>Expressions</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Description</b></td><td><b>Language</b></td><td><b>Expression</b></td></tr><tr><td style="display: none">*</td><td>Due date of the dose</td><td>text/cql-identifier</td><td>MCV2 Schedule Date</td></tr></table></blockquote><blockquote><p><b>dynamicValue</b></p><p><b>path</b>: dispenseRequest.validityPeriod.end</p><h3>Expressions</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Description</b></td><td><b>Language</b></td><td><b>Expression</b></td></tr><tr><td style="display: none">*</td><td>Expiration date for MCV dose</td><td>text/cql-identifier</td><td>MCV2 Expiration Date</td></tr></table></blockquote></blockquote></blockquote><blockquote><p><b>action</b></p><p><b>CPG Rationale Extension</b>: </p><div><p>An additional dose of MCV should be administered to HIV-infected children receiving HAART following immune reconstitution. If CD4+ T lymphocyte counts are monitored, an additional dose of MCV should be administered when immune reconstitution has been achieved, e.g. when the CD4+ T lymphocyte count reaches 20–25%. Where CD4+ T lymphocyte monitoring is not available, children should receive an additional dose of MCV 6–12 months after initiation of HAART.</p>
</div><p><b>title</b>: Measles primary series is complete</p><p><b>description</b>: Measles primary series is complete. Two measles primary series doses were administered. Check if a measles supplementary dose is appropriate for the client.</p><blockquote><p><b>condition</b></p><p><b>kind</b>: Applicability</p><h3>Expressions</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Language</b></td><td><b>Expression</b></td></tr><tr><td style="display: none">*</td><td>text/cql-identifier</td><td>Two Primary Series Doses Administered</td></tr></table></blockquote></blockquote></blockquote></div>
</text>
<extension
url="http://hl7.org/fhir/StructureDefinition/cqf-knowledgeCapability">
<valueCode value="computable"/>
</extension>
<url
value="http://smart.who.int/example-workshop/PlanDefinition/IMMZD2DTMeaslesOT"/>
<version value="0.1.0"/>
<name value="IMMZD2DTMeaslesOT"/>
<title value="IMMZ.D2.DT.Measles Ongoing Transmission"/>
<type>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/plan-definition-type"/>
<code value="eca-rule"/>
</coding>
</type>
<status value="draft"/>
<experimental value="true"/>
<date value="2024-12-02T20:31:54+00:00"/>
<publisher value="WHO"/>
<contact>
<name value="WHO"/>
<telecom>
<system value="url"/>
<value value="http://who.int"/>
</telecom>
</contact>
<description
value="If the child or patient has not been given MCV1 (at 9 months) and MCV2 (between 15-18 months) vaccination"/>
<relatedArtifact>
<type value="citation"/>
<citation
value="WHO recommendations for routine immunization - summary tables (March 2023)"/>
</relatedArtifact>
<library
value="http://smart.who.int/example-workshop/Library/IMMZD2DTMeaslesOTLogic"/>
<action>
<title value="Immunize patient for Measles"/>
<condition>
<kind value="applicability"/>
<expression>
<language value="text/cql-identifier"/>
<expression value="Measles Routine Immunization Schedule Incomplete"/>
</expression>
</condition>
<action>
<extension
url="http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-rationale">
<valueMarkdown
value="In countries with ongoing transmission in which the risk of measles mortality remains high, MCV1 should be given at age 9 months.<br/>As a general rule, live vaccines should be given either simultaneously or at intervals of 4 weeks. An exception to this rule is OPV, which can be given at any time before or after measles vaccination without interference in the response to either vaccine."/>
</extension>
<title value="Provide primary series measles vaccination (MCV1)"/>
<condition>
<kind value="applicability"/>
<expression>
<language value="text/cql-identifier"/>
<expression value="No Primary Series Doses Administered"/>
</expression>
</condition>
<action>
<title value="Client Age Less Than 9 Months"/>
<description
value="Should not vaccinate client as client's age is less than 9 months. Check for any vaccines due, and inform the caregiver of when to come back for MCV1."/>
<condition>
<kind value="applicability"/>
<expression>
<language value="text/cql-identifier"/>
<expression value="Client Age Less Than 9 Months"/>
</expression>
</condition>
</action>
<action>
<title value="Last Live Vaccine Administered Within 4 Weeks"/>
<description
value="Should not vaccinate client for MCV1 as live vaccine was administered in the last 4 weeks. Check for any vaccines due and inform the caregiver of when to come back for MCV1."/>
<condition>
<kind value="applicability"/>
<expression>
<language value="text/cql-identifier"/>
<expression
value="Last Live Vaccine Administered Within 4 Weeks"/>
</expression>
</condition>
</action>
<action>
<title value="Provide Measles Vaccine"/>
<description
value="Should vaccinate client for MCV1 as no measles doses were administered, client is within appropriate age range and no live vaccine administered in the last 4 weeks. Check for contraindications."/>
<condition>
<kind value="applicability"/>
<expression>
<language value="text/cql-identifier"/>
<expression value="Client Is Due For MCV1"/>
</expression>
</condition>
<definitionCanonical
value="http://smart.who.int/example-workshop/ActivityDefinition/IMMZD2DTMeaslesMR"/>
<dynamicValue>
<path value="dispenseRequest.validityPeriod.start"/>
<expression>
<description value="Due date of the dose"/>
<language value="text/cql-identifier"/>
<expression value="MCV1 Schedule Date"/>
</expression>
</dynamicValue>
<dynamicValue>
<path value="dispenseRequest.validityPeriod.end"/>
<expression>
<description value="Expiration date for MCV dose"/>
<language value="text/cql-identifier"/>
<expression value="MCV1 Expiration Date"/>
</expression>
</dynamicValue>
</action>
</action>
<action>
<extension
url="http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-rationale">
<valueMarkdown
value="In countries with ongoing transmission in which the risk of measles mortality remains high, MCV2 should be given between 15-18 months. The minimum interval between MCV1 and MCV2 is 4 weeks.<br/>As a general rule, live vaccines should be given either simultaneously or at intervals of 4 weeks. An exception to this rule is OPV, which can be given at any time before or after measles vaccination without interference in the response to either vaccine."/>
</extension>
<title value="Provide primary series measles vaccination (MCV2)"/>
<condition>
<kind value="applicability"/>
<expression>
<language value="text/cql-identifier"/>
<expression value="One Primary Series Dose Administered"/>
</expression>
</condition>
<action>
<title value="Client Age Less Than 15 Months"/>
<description
value="Should not vaccinate client for MCV2 as client's age is less than 15 months. Check for any vaccines due, and inform the caregiver of when to come back for MCV2."/>
<condition>
<kind value="applicability"/>
<expression>
<language value="text/cql-identifier"/>
<expression value="Client Age Less Than 15 Months"/>
</expression>
</condition>
</action>
<action>
<title value="Last Live Vaccine Administered Within 4 Weeks"/>
<description
value="Should not vaccinate client for MCV2 as live vaccine was administered in the last 4 weeks. Check for any vaccines due, and inform the caregiver of when to come back for MCV2."/>
<condition>
<kind value="applicability"/>
<expression>
<language value="text/cql-identifier"/>
<expression
value="Last Live Vaccine Administered Within 4 Weeks"/>
</expression>
</condition>
</action>
<action>
<title value="Provide Measles Vaccine"/>
<description
value="Should vaccinate client for MCV2 as client is within appropriate age range and no live vaccine administered in the last 4 weeks. Check for contraindications."/>
<condition>
<kind value="applicability"/>
<expression>
<language value="text/cql-identifier"/>
<expression value="Client Is Due For MCV2"/>
</expression>
</condition>
<definitionCanonical
value="http://smart.who.int/example-workshop/ActivityDefinition/IMMZD2DTMeaslesMR"/>
<dynamicValue>
<path value="dispenseRequest.validityPeriod.start"/>
<expression>
<description value="Due date of the dose"/>
<language value="text/cql-identifier"/>
<expression value="MCV2 Schedule Date"/>
</expression>
</dynamicValue>
<dynamicValue>
<path value="dispenseRequest.validityPeriod.end"/>
<expression>
<description value="Expiration date for MCV dose"/>
<language value="text/cql-identifier"/>
<expression value="MCV2 Expiration Date"/>
</expression>
</dynamicValue>
</action>
</action>
<action>
<extension
url="http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-rationale">
<valueMarkdown
value="An additional dose of MCV should be administered to HIV-infected children receiving HAART following immune reconstitution. If CD4+ T lymphocyte counts are monitored, an additional dose of MCV should be administered when immune reconstitution has been achieved, e.g. when the CD4+ T lymphocyte count reaches 20–25%. Where CD4+ T lymphocyte monitoring is not available, children should receive an additional dose of MCV 6–12 months after initiation of HAART."/>
</extension>
<title value="Measles primary series is complete"/>
<description
value="Measles primary series is complete. Two measles primary series doses were administered. Check if a measles supplementary dose is appropriate for the client."/>
<condition>
<kind value="applicability"/>
<expression>
<language value="text/cql-identifier"/>
<expression value="Two Primary Series Doses Administered"/>
</expression>
</condition>
</action>
</action>
</PlanDefinition>